About Kanzler Biologicals

Kanzler Biologicals documents a commercial preclinical research and development project focused on artificial-heart engineering, mechanical circulatory support and regenerative cardiovascular research. Development work has been ongoing since 2017, moving from initial membrane-pump concepts toward a modular two-circuit architecture with defined safety and validation planning.

The project is organized around a single technical dossier rather than marketing pages: every module — systemic pump, pulmonary pump, pulse chamber, bypass safety logic, sensor network, battery and inductive charging — is documented with concept values, and every value is labelled as either confirmed or still pending bench validation.

This site does not describe an approved medical device, a treatment, or a product for sale. It is preclinical engineering documentation published for transparency, with an explicit validation plan (see Research) and a running development logbook (see Timeline).